Multiple sclerosis (MS) is a chronic disease of the central nervous system that disrupts communication between the brain, spinal cord, and the rest of the body. A defining feature of the disease is damage to myelin, the protective, insulating material surrounding many nerve fibers. When myelin is damaged, electrical signals can slow down, become unreliable, or fail to reach their intended destinations.
This disruption helps explain why MS can affect such a wide range of functions, including movement, sensation, vision, balance, coordination, and thinking. The symptoms depend largely on where damage occurs, how extensive it is, and whether the underlying nerve fibers remain intact.
Understanding MS requires looking beyond myelin itself. The disease involves an abnormal immune response, inflammation within the central nervous system, changes to the nerve fibers that carry signals, and varying degrees of tissue repair. These processes help determine whether symptoms resolve, persist, or gradually worsen.
What myelin does in a healthy nervous system
The nervous system relies on specialized cells called neurons to receive, process, and transmit information. Each neuron has extensions that allow it to communicate with other neurons or with muscles and sensory structures. One of these extensions, the axon, carries electrical signals away from the neuron’s cell body.
Many axons are surrounded by myelin, a fatty, protein-rich substance arranged in multiple layers around the nerve fiber. Myelin is produced by different cells in different parts of the nervous system. In the brain and spinal cord, it is made by cells called oligodendrocytes. In peripheral nerves, which extend outside the brain and spinal cord, myelin is produced by Schwann cells.
Myelin serves two closely related purposes: it insulates the axon and allows electrical signals to travel efficiently along it.
In an unmyelinated axon, an electrical impulse must be regenerated continuously along the cell membrane. In a myelinated axon, the myelin sheath reduces the loss of electrical current across most of the membrane. The impulse is regenerated primarily at small gaps between adjacent myelin segments, called nodes of Ranvier.
This process, known as saltatory conduction, allows the electrical signal to appear to jump from one node to the next. It makes transmission faster and more energy-efficient than continuous conduction along an unmyelinated fiber of comparable diameter.
Myelin is therefore not simply a protective coating. It is an essential part of the machinery that enables the nervous system to coordinate rapid, precisely timed communication.
The timing matters. Walking, for example, requires the brain and spinal cord to coordinate many muscle groups while processing information about body position and balance. Sensory signals must arrive accurately enough for the nervous system to adjust movement from moment to moment. Damage that interferes with the speed or reliability of these signals can disrupt even familiar activities.
What happens to myelin in multiple sclerosis
Multiple sclerosis is an immune-mediated disease of the central nervous system. This means that immune activity contributes to damage in the brain, spinal cord, and optic nerves, which carry visual information from the eyes to the brain.
In MS, immune cells and inflammatory signals enter or become active within central nervous system tissue and contribute to injury involving myelin, oligodendrocytes, and sometimes the axons themselves. The precise sequence of events varies, and the full set of mechanisms that initiates and sustains the disease is not completely understood.
One important feature of MS is demyelination: the loss or disruption of the myelin sheath around nerve fibers.
When myelin is damaged, the affected axon loses some of its electrical insulation. Current can escape across the membrane, making it harder for the signal to propagate efficiently. The exposed membrane may also lack the normal distribution of ion channels needed for reliable electrical conduction.
As a result, signals can travel more slowly, arrive with altered timing, or fail altogether. This failure is called conduction block.
The effects depend on the location and severity of the lesion, the term used for an area of damaged tissue. A lesion in a pathway responsible for visual information can affect sight, while a lesion in a motor pathway can interfere with muscle control. Damage in sensory pathways can alter the perception of touch, temperature, or pain.
MS lesions may develop in different locations and at different times. This scattered pattern helps explain why the disease does not produce one consistent set of symptoms in every person.
Why damaged myelin disrupts electrical signals
The electrical behavior of a nerve fiber depends on the movement of charged particles, particularly sodium and potassium ions, across its cell membrane. Changes in electrical voltage trigger an action potential, the brief electrical event that carries a nerve signal along the axon.
Myelin helps maintain the conditions needed for this signal to travel rapidly. When the sheath is disrupted, the axon must work harder to transmit the impulse. The electrical current may dissipate before it can activate the next section of membrane, especially when the damage is extensive.
Some demyelinated axons can still conduct signals, but more slowly or less reliably. Others may temporarily or persistently lose the ability to transmit them.
Inflammation can compound these effects. Changes in the local chemical environment and the activity of immune cells can interfere with nerve function even before permanent structural damage occurs.
This distinction matters because not every symptom during an MS episode indicates that nerve fibers have been permanently destroyed. Some problems arise from temporarily impaired conduction and can improve as inflammation subsides and the tissue recovers.
Why the immune system attacks myelin
The immune system normally protects the body against infections and other threats. In autoimmune and immune-mediated diseases, immune responses contribute to injury in the body’s own tissues. In MS, immune activity targets components of the central nervous system and creates an inflammatory environment that damages myelin and can injure other neural structures.
The exact cause of MS is not fully established. It is understood to arise through a complex interaction of genetic susceptibility, environmental influences, and immune-system activity rather than from a single cause.
Certain immune cells, including T cells and B cells, participate in the disease. T cells can promote inflammation and influence other immune cells. B cells can present antigens to T cells and produce antibodies, among other functions. Antibodies are proteins that recognize specific molecular targets. Their role in MS is complex, and the disease cannot be explained simply as the production of antibodies against myelin.
Inflammatory activity can damage the myelin sheath, harm the cells that produce it, and alter the surrounding tissue. In some lesions, the blood-brain barrier, a system of specialized blood-vessel cells that regulates what enters the central nervous system, becomes more permeable. This allows immune cells and inflammatory substances to enter tissue that is normally tightly protected from circulating blood.
Why these immune responses develop in a particular person remains uncertain. Researchers have identified multiple factors associated with MS risk, but no single factor explains all cases. Genetics can influence susceptibility without determining whether someone will develop the disease, and environmental exposures can contribute to risk without guaranteeing that it will occur.
MS is not caused by a person’s behavior or by a simple failure of the immune system. It is a complex biological disorder whose underlying mechanisms continue to be investigated.
How myelin damage produces different symptoms
The symptoms of MS depend on which neural pathways are affected. Because the brain and spinal cord control many interconnected functions, lesions in different locations can produce very different effects, even when the underlying process is similar.
Movement, strength, and coordination
Motor pathways carry commands from the brain through the spinal cord to muscles. When MS damages these pathways, the resulting disruption can cause weakness, difficulty controlling movement, or problems with walking.
Damage to pathways involved in muscle tone can also cause spasticity, a condition in which muscles become unusually stiff and resist movement. Muscle spasms may accompany this stiffness.
Balance and coordination can be affected when lesions involve the cerebellum, a brain region that helps coordinate movement, or the pathways connecting it to other parts of the nervous system. A person may experience unsteadiness, tremor during purposeful movement, or difficulty performing tasks that require precise coordination.
These problems do not necessarily mean the muscles themselves are diseased. In many cases, the muscles cannot receive or process neural commands normally because communication pathways have been disrupted.
Sensation, pain, and unusual nerve signals
Sensory pathways carry information about touch, temperature, pain, vibration, and the position of body parts. Damage along these pathways can produce numbness, tingling, burning sensations, or altered sensitivity.
Some people experience sensations without an obvious external stimulus. These are called paresthesias and may include pins and needles, prickling, or a feeling of electrical activity.
Pain can arise through several mechanisms in MS. Damage to sensory pathways may produce neuropathic pain, which results from abnormal signaling in the nervous system. Muscle stiffness, spasms, and changes in posture can also contribute to pain.
Because sensory information travels through pathways that cross, branch, and connect at different levels, the location of a lesion influences which body regions are affected and how symptoms are experienced.
Vision and eye movement
The optic nerves transmit visual information from the retina to the brain. Inflammation and demyelination of an optic nerve can cause optic neuritis, a common manifestation of MS.
Symptoms may include blurred vision, reduced color perception, pain with eye movement, or partial loss of vision in the affected eye. The severity and duration vary, and vision often improves as inflammation resolves, although some people retain lasting visual changes.
MS can also affect the brain pathways that coordinate eye movements. This may cause double vision, involuntary eye movements, or difficulty keeping the eyes aligned.
These visual symptoms illustrate how the same underlying disease process can produce different problems depending on the specific nerve structures involved.
Fatigue, thinking, and other functions
Fatigue is one of the most common and potentially disabling symptoms of MS. It is more than ordinary tiredness after exertion. It can involve a persistent sense of physical or mental exhaustion that interferes with daily activities.
Its causes are not fully understood and may include several interacting factors: the increased effort required to perform tasks when neural pathways are impaired, inflammatory processes, disrupted sleep, medication effects, pain, and the emotional burden of living with a chronic illness. Heat can also temporarily worsen symptoms in some people with MS.
Cognitive changes may affect attention, information-processing speed, memory, or the ability to organize complex tasks. These difficulties vary widely and do not mean that every person with MS will experience substantial cognitive impairment.
Lesions affecting the spinal cord and brainstem can also disrupt bladder and bowel control, sexual function, swallowing, or other automatic processes. The range of possible symptoms reflects the central nervous system’s responsibility for coordinating nearly every major function of the body.
Why symptoms can come and go
MS symptoms often fluctuate because inflammation, conduction failure, and tissue repair change over time. The course of the disease differs among individuals, but many people experience periods when new symptoms develop or existing ones worsen, followed by partial or substantial recovery.
An episode of new or worsening neurological symptoms caused by inflammatory activity is commonly called a relapse. Relapses generally develop over hours to days and persist for a period of time, rather than appearing as momentary fluctuations. Other causes of neurological symptoms must be considered before an episode is attributed to MS.
During an active lesion, inflammation and demyelination can impair nerve conduction. As inflammation subsides, some nerve fibers regain the ability to transmit signals more effectively. This can lead to symptom improvement, even when the original myelin sheath has not been fully restored.
Temperature can also affect the performance of demyelinated nerve fibers. A rise in body temperature, whether from exercise, a hot environment, or fever, can make conduction less reliable in some damaged pathways. Symptoms that had previously improved may temporarily return or intensify. This phenomenon is known as Uhthoff’s phenomenon when it involves temperature-related worsening of neurological symptoms, particularly visual symptoms.
Such worsening does not necessarily indicate a new lesion or additional permanent damage. Symptoms caused by heat often improve when the body cools.
In contrast, a genuine relapse reflects new or renewed inflammatory activity. Infections and other physiological stresses can also temporarily worsen existing MS symptoms without causing a new inflammatory lesion.
The distinction between temporary symptom worsening, a relapse, and gradual disease progression is clinically important because these processes have different implications for evaluation and treatment.
What happens when the nervous system tries to repair myelin
The central nervous system has some capacity to repair damaged myelin through a process called remyelination. This process depends on precursor cells that can develop into mature oligodendrocytes, which then produce new myelin around surviving axons.
Remyelination can restore some of the electrical insulation lost during demyelination. Newly formed myelin sheaths are often thinner and shorter than the original sheaths, but they can still improve the efficiency of signal transmission.
This repair helps explain why some neurological symptoms improve after an MS relapse. Recovery can also result from the resolution of inflammation and the restoration of function in nerve fibers that were temporarily impaired rather than permanently injured.
However, remyelination is not always complete. Its effectiveness varies among lesions and individuals, and the reasons some areas repair better than others are still being studied. Over time, some lesions become chronically demyelinated, with limited restoration of the original myelin structure.
The survival of the axon is critical. Replacing myelin can improve the function of a surviving nerve fiber, but it cannot fully restore an axon that has been destroyed.
This is one reason MS is more than a disease of myelin alone. Although demyelination is a defining feature, injury to axons and neurons is also an important source of lasting disability.
How repeated injury can lead to permanent damage
Myelin normally supports the long-term health of axons as well as their electrical performance. When the sheath is lost, the axon must adapt to maintain conduction, including by redistributing ion channels along the exposed membrane. These changes can help signals continue to travel, but they can also increase the energy demands placed on the nerve fiber.
If an axon remains demyelinated and under stress, it may become more vulnerable to additional injury. Inflammation can contribute directly to axonal damage, while impaired energy balance may make it harder for a nerve fiber to maintain its structure and function.
Axonal injury can range from subtle structural abnormalities to complete loss of the fiber. When axons are permanently lost, the nervous system loses part of the communication network that connects its regions. The brain has some capacity to reorganize its activity and compensate for damage, but this ability has limits.
Repeated inflammatory injury and incomplete repair can therefore produce cumulative neurological impairment. A person may initially recover well from individual relapses but later experience persistent difficulties as the burden of tissue damage increases.
MS can also involve slowly evolving injury that is not captured fully by obvious relapses. Some lesions remain active at their edges or sustain low-level inflammation over time. Changes in brain and spinal cord tissue may continue even when acute symptoms are absent.
This helps explain why disability can accumulate in some people despite relatively few noticeable attacks. It also explains why modern approaches to MS increasingly consider not only acute inflammation and demyelination but also chronic tissue injury and neurodegeneration, the progressive loss of neurons and their connections.
The different courses of multiple sclerosis
MS does not follow one uniform pattern. Clinicians distinguish several disease courses based on how symptoms develop, recover, and change over time.
In relapsing-remitting MS, episodes of new or worsening neurological symptoms are followed by periods of partial or substantial recovery. Inflammation and demyelination often play a prominent role during relapses, although the extent of recovery depends on the location and severity of the injury and the degree of tissue repair.
Some people later develop secondary progressive MS, characterized by a gradual accumulation of disability over time. Relapses may continue, become less frequent, or no longer be a prominent feature. Progression can reflect a combination of earlier tissue damage and ongoing processes within the central nervous system.
Primary progressive MS is characterized by gradual worsening from the beginning of the disease, without the distinct early pattern of relapses and remissions typical of relapsing-remitting MS. The rate and pattern of progression vary among individuals.
These categories describe clinical patterns rather than completely separate biological diseases. Inflammation, demyelination, remyelination, and axonal injury can occur in overlapping ways across the different courses.
The distinction is useful because disease course helps clinicians assess prognosis, monitor changes, and choose appropriate treatments. However, no category predicts every aspect of an individual’s future health.
How treatments address myelin damage and inflammation
There is currently no cure that reliably eliminates MS or fully restores all damaged myelin and nerve fibers. Nevertheless, treatments can reduce disease activity, help manage symptoms, and support daily functioning.
Disease-modifying therapies primarily aim to alter the immune processes that drive MS. Depending on the treatment, they may reduce immune-cell activity, limit the movement of immune cells into the central nervous system, or change how immune cells function. Many are effective at reducing relapses and new inflammatory lesions, and some also reduce the risk of disability accumulation.
These therapies do not all work in the same way, and their benefits and risks differ. They are selected according to factors such as disease activity, individual health considerations, and treatment goals.
Treatments for acute relapses may include corticosteroids, which reduce inflammation and can speed recovery from an attack. They do not directly rebuild myelin or guarantee complete recovery, and they are not used to treat every temporary worsening of symptoms.
Symptom-directed care addresses specific consequences of nervous system damage. Depending on a person’s needs, this may include medications for spasticity or neuropathic pain, rehabilitation to improve mobility and coordination, physical and occupational therapy, strategies to manage fatigue, and treatment for bladder, bowel, sleep, or mood difficulties.
Research is also exploring ways to promote remyelination and protect axons from degeneration. These approaches address an important limitation of existing therapies: controlling inflammation can reduce new injury, but restoring tissue already damaged by MS remains difficult.
The distinction between preventing damage and repairing it is central to understanding treatment. Preserving functioning nerve fibers can help maintain the nervous system’s existing capacity, while successful remyelination could improve conduction in surviving axons. Replacing lost neurons and rebuilding complex neural connections, however, presents a substantially greater challenge.
Why understanding myelin matters
Myelin damage explains much of the immediate neurological dysfunction in multiple sclerosis, from slowed nerve signaling to the temporary loss of function during an inflammatory attack. The location of each lesion determines which pathways are affected, while inflammation and repair influence how symptoms change over time.
Yet the long-term effects of MS depend on more than the myelin sheath. The ability of oligodendrocytes to repair damage, the survival of axons, the persistence of inflammation, and the nervous system’s capacity to compensate all shape the disease’s course.
This broader view also clarifies why MS varies so much from one person to another. Two people may have the same diagnosis but different symptoms, different patterns of recovery, and different levels of disability because their lesions affect different neural structures and their nervous systems respond differently to injury.
The central challenge in MS is therefore twofold: preventing immune-mediated damage and preserving or restoring the neural connections that make normal nervous system function possible. Understanding how myelin, inflammation, and axonal health interact provides the foundation for both current treatment strategies and the search for therapies that can repair more of the damage the disease causes.
